Alcidion Group 관리

관리 기준 확인 2/4

Alcidion Group CEO는 Kate Quirke, Jul2018 에 임명되었습니다 의 임기는 6.25 년입니다. 총 연간 보상은 A$ 602.43K, 86.8% 로 구성됩니다. 86.8% 급여 및 13.2% 보너스(회사 주식 및 옵션 포함). 는 A$ 2.53M 가치에 해당하는 회사 주식의 3.62% 직접 소유합니다. 2.53M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 3.1 년입니다.

주요 정보

Kate Quirke

최고 경영자

AU$602.4k

총 보상

CEO 급여 비율	86.8%
CEO 임기	6.3yrs
CEO 소유권	3.6%
경영진 평균 재임 기간	1.8yrs
이사회 평균 재임 기간	3.1yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Kate Quirke 의 보수는 Alcidion Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	AU$602k	AU$523k	-AU$8m
Mar 31 2024	n/a	n/a	-AU$7m
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$4m
Jun 30 2023	AU$708k	AU$473k	-AU$4m
Mar 31 2023	n/a	n/a	-AU$2m
Dec 31 2022	n/a	n/a	-AU$1m
Sep 30 2022	n/a	n/a	-AU$3m
Jun 30 2022	AU$611k	AU$398k	-AU$4m
Mar 31 2022	n/a	n/a	-AU$6m
Dec 31 2021	n/a	n/a	-AU$7m
Sep 30 2021	n/a	n/a	-AU$5m
Jun 30 2021	AU$615k	AU$388k	-AU$2m
Mar 31 2021	n/a	n/a	-AU$2m
Dec 31 2020	n/a	n/a	-AU$3m
Sep 30 2020	n/a	n/a	-AU$3m
Jun 30 2020	AU$472k	AU$348k	-AU$3m
Mar 31 2020	n/a	n/a	-AU$2m
Dec 31 2019	n/a	n/a	-AU$1m
Sep 30 2019	n/a	n/a	-AU$683k
Jun 30 2019	AU$430k	AU$250k	-AU$84k

보상 대 시장: Kate 의 총 보상 ($USD 396.15K )은 Australian 시장( $USD 299.30K ).

보상과 수익: Kate 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Kate Quirke

6.3yrs

테뉴어

AU$602,428

보상

Ms. Kate Quirke has been Chief Executive Officer and Executive Director of Alcidion Group Ltd. since July 3, 2018 and has been its Group Managing Director since January 25, 2019. Ms. Quirke served as Chief...

리더십 팀

이름	위치	테뉴어	보상	소유권
Kate Quirke	Group MD	6.3yrs	AU$602.43k	3.62% A$ 2.5m
Matthew Gepp	Chief Financial Officer	3.3yrs	AU$355.74k	데이터 없음
Julia Stevens	Chief Operating Officer	less than a year	데이터 없음	데이터 없음
Vivek Krishnan	Chief Technology Officer	no data	데이터 없음	데이터 없음
Kerstin Wahlqvist	Investor Relations Manager	no data	데이터 없음	데이터 없음
Maria Hunter	Group General Counsel	3.8yrs	데이터 없음	데이터 없음
Nick White	Chief Marketing Officer	1.8yrs	데이터 없음	데이터 없음
Tracey Harvey	Human Resources Manager	no data	데이터 없음	데이터 없음
Kaye Hocking	Chief Product Officer	no data	데이터 없음	데이터 없음
Amanda James	Chief People Officer	no data	데이터 없음	데이터 없음
Paul Deffley	Chief Medical Officer	less than a year	데이터 없음	데이터 없음
Michael Sapountzis	Company Secretary	no data	데이터 없음	데이터 없음

1.8yrs

평균 재임 기간

경험이 풍부한 관리: ALC 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kate Quirke	Group MD	6.3yrs	AU$602.43k	3.62% A$ 2.5m
Victoria Sophia Weekes	Independent Non-Executive Director	3.1yrs	AU$75.00k	0.031% A$ 21.8k
Rebecca Wilson	Independent Chair	7.2yrs	AU$120.00k	0.14% A$ 99.4k
Daniel Sharp	Independent Non-Executive Director	3.1yrs	AU$75.00k	0.10% A$ 71.7k
William Smart	Non-Executive Director	no data	데이터 없음	데이터 없음

3.1yrs

평균 재임 기간

경험이 풍부한 이사회: ALC 의 이사회는 경험(평균 재직 기간 3.1 년)으로 간주됩니다.

Alcidion Group 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Alcidion Group Limited Announces Change of Company Secretary

Insufficient new directors

Alcidion Group Limited, Annual General Meeting, Oct 23, 2024

Alcidion Group Limited Announces Board and Committee Changes

Alcidion Group Limited, Annual General Meeting, Nov 20, 2023

Independent Non-Executive Director recently bought AU$55k worth of stock

Recent updates

Alcidion Group Limited Announces Change of Company Secretary

Insufficient new directors

Alcidion Group Limited, Annual General Meeting, Oct 23, 2024

Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.003 loss in FY 2023)

Alcidion Group Limited Announces Board and Committee Changes

Alcidion Group Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

Alcidion Group Limited to Report Q4, 2024 Results on Jul 30, 2024

Forecast to breakeven in 2025

Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024

Alcidion Group Limited to Report Q3, 2024 Results on Apr 18, 2024

New minor risk - Profitability

Alcidion Group Limited to Report First Half, 2024 Results on Feb 28, 2024

Alcidion Group Limited to Report Q2, 2024 Results on Jan 31, 2024

Alcidion Group Limited has completed a Follow-on Equity Offering in the amount of AUD 5.025 million.

New minor risk - Shareholder dilution

Alcidion Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

Alcidion Group Limited to Report Q1, 2024 Results on Oct 31, 2023

Alcidion Group Limited, Annual General Meeting, Nov 20, 2023

Now 22% undervalued

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022)

Alcidion Group Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Alcidion Group Limited to Report Q4, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

Independent Non-Executive Director recently bought AU$55k worth of stock

Forecast breakeven date moved forward to 2023

Forecast breakeven date pushed back to 2024

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in 1H 2022)

Alcidion Group Limited to Report First Half, 2023 Results on Feb 24, 2023

Alcidion Group Limited to Report First Half, 2023 Results on Jan 30, 2023

Alcidion Group Limited Announces Malcolm Pradhan Stepping Down as Executive Director and Chief Medical Officer

Alcidion Group Limited to Report Q1, 2023 Results on Oct 31, 2022

Full year 2022 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in FY 2021)

Alcidion Group Limited, Annual General Meeting, Oct 25, 2022

Alcidion Group Limited to Report Fiscal Year 2022 Results on Aug 30, 2022

Alcidion Group Limited to Report Q4, 2022 Results on Jul 27, 2022

Forecast breakeven date pushed back to 2023

Alcidion Group Limited to Report Q3, 2022 Results on Apr 27, 2022

Forecast breakeven date pushed back to 2023

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Alcidion Group Limited to Report First Half, 2022 Results on Feb 23, 2022

Alcidion Group Limited (ASX:ALC) completed the acquisition of Silverlink Software Limited.

Alcidion Group Limited (ASX:ALC) agreed to acquire Silverlink Software Limited for £33 million.

Forecast to breakeven in 2022

Less than half of directors are independent

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Alcidion Group Limited Provides Earnings Guidance for the Fiscal 2022

Co-Founder & Non-Executive Director Raymond Blight has left the company

Insider recently bought AU$3.9m worth of stock

Alcidion Signs Contract with Te Manawa Taki DHBs for Electronic Medication Management

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

New 90-day high: AU$0.26

Alcidion Group Limited to Report First Half, 2021 Results on Feb 25, 2021

New 90-day high: AU$0.21

Alcidion Group Limited to Report Q2, 2021 Results on Jan 27, 2021

Alcidion Group Limited Announces an Extension of its Contract with South Tees Hospitals NHS Foundation Trust

Alcidion Group Limited Announces Reseller Agreement with Nextgate Solutions, Inc

New 90-day high: AU$0.21

Alcidion Group Limited Signs $9.5 Million Deal with NHS Trust

Alcidion Group Limited to Report Q1, 2021 Results on Oct 27, 2020

Insider recently bought AU$195k worth of stock

Full year earnings released - AU$0.0033 loss per share

Alcidion Group Limited to Report Fiscal Year 2020 Results on Aug 27, 2020

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

이사회 구성원